- Acne
- Actinic Keratosis
- Aesthetics
- Alopecia
- Atopic Dermatitis
- Buy-and-Bill
- COVID-19
- Case-Based Roundtable
- Chronic Hand Eczema
- Drug Watch
- Eczema
- General Dermatology
- Hidradenitis Suppurativa
- Melasma
- NP and PA
- Pediatric Dermatology
- Pigmentary Disorders
- Practice Management
- Precision Medicine and Biologics
- Prurigo Nodularis
- Psoriasis
- Psoriatic Arthritis
- Rare Disease
- Rosacea
- Skin Cancer
- Vitiligo
- Wound Care
Publication
Article
Dermatology Times
Dermatology Times, August 2019 (Vol. 39, No. 8)Volume39 Issue No. 8
Comprehensive psoriasis management
Author(s):
The August issue of Dermatology Times includes a supplement edition that focuses on a patient-centered approach in psoriasis management, including an article on the importance of longer consults in the doctor's office and recommendations for individualized therapy. Read more here.
The August issue of Dermatology Times includes a supplement edition that focuses on a patient-centered approach in psoriasis management, including an article on the importance of longer consults in the doctor's office and recommendations for individualized therapy.
Articles in this issue
Communication in the era of patient-centered care
Comprehensive psoriasis management
Dermatology training for nurses and PAs
Is it time to regulate probiotics in cosmetics?
11 steps to improving doctor-patient communication
Language used in medical records can stigmatize patients for years
EC moves forward with new PsA treatment
Make patient-centered work in practice
New AAD cSCC treatment guidelines
Emotional burden of skin conditions may be rooted in physiology
Outlook for new botulinum toxins in the U.S. market
FDA approves treatment for underarm sweating
Analysis shows nurses are overworked
The science behind acne scarring
IL-23 guselkumab significantly improves symptoms in psoriatic arthritis
Related Videos
IL-17 Inhibitor Treatment Impact on Quality of Life in Psoriasis and Psoriatic Arthritis
Clinical Attributes of IL-17 Inhibitors in Psoriasis
Mechanism of Action Differences Among IL-17 Inhibitors
The Role of IL-17 in Psoriasis Pathogenesis
New Research Confirms Effective Therapy for Nail Psoriasis
New Biomarker Test Revolutionizes Inflammatory Skin Disease Diagnosis
Jeff Stark, MD: Discussing Bimzelx’s Efficacy and Future in Treating Inflammatory Skin Diseases
Addressing Disparities in Inflammatory Skin Diseases in Darker Skin Tones
Jeff Stark, MD: Reviewing UCB's Abstracts Across HS, PsO, PsA, and More
Pipeline Updates on the Horizon From Arcutis Biotherapeutics
Related Content
